Cancer-linked DNA hypomethylation and its relationship to hypermethylation
- PMID: 16909914
- DOI: 10.1007/3-540-31181-5_12
Cancer-linked DNA hypomethylation and its relationship to hypermethylation
Abstract
It is not surprising that cancer, a kind of derangement of development, hijacks DNA methylation, which is necessary for normal mammalian embryogenesis. Both decreases and increases in DNA methylation are a frequent characteristic of a wide variety of cancers. There is often more hypomethylation than hypermethylation of DNA during carcinogenesis, leading to a net decrease in the genomic 5-methylcytosine content. Although the exact methylation changes between different cancers of the same type are not the same, there are cancer type-specific differences in the frequency of hypermethylation or hypomethylation of certain genomic sequences. These opposite types of DNA methylation changes appear to be mostly independent of one another, although they may arise because of a similar abnormality leading to long-lasting epigenetic instability in cancers. Both tandem and interspersed DNA repeats often exhibit cancer-associated hypomethylation. However, one of these repeated sequences (NBL2) displayed predominant increases in methylation in some ovarian carcinomas and Wilms tumors and decreases in others. Furthermore, decreases and increases in CpG methylation can be interspersed within a small subregion of the 1.4-kb repeat unit of these tandem arrays. While the transcription-silencing role of DNA hypermethylation at promoters of many tumor-suppressor genes is clear, the biological effects of cancer-linked hypomethylation of genomic DNA are less well understood. Evidence suggests that DNA hypomethylation functions in direct or indirect control of transcription and in destabilizing chromosomal integrity. Recent studies of cancer-linked DNA hypomethylation indicate that changes to DNA methylation during tumorigenesis and tumor progression have a previously underestimated plasticity and dynamic nature.
Similar articles
-
Both hypomethylation and hypermethylation in a 0.2-kb region of a DNA repeat in cancer.Mol Cancer Res. 2005 Nov;3(11):617-26. doi: 10.1158/1541-7786.MCR-05-0146. Mol Cancer Res. 2005. PMID: 16317087 Free PMC article.
-
A DNA repeat, NBL2, is hypermethylated in some cancers but hypomethylated in others.Cancer Biol Ther. 2005 Apr;4(4):440-8. doi: 10.4161/cbt.4.4.1622. Epub 2005 Apr 21. Cancer Biol Ther. 2005. PMID: 15846090
-
The controversial denouement of vertebrate DNA methylation research.Biochemistry (Mosc). 2005 May;70(5):568-75. doi: 10.1007/s10541-005-0150-z. Biochemistry (Mosc). 2005. PMID: 15948710
-
DNA methylation in cancer: too much, but also too little.Oncogene. 2002 Aug 12;21(35):5400-13. doi: 10.1038/sj.onc.1205651. Oncogene. 2002. PMID: 12154403 Review.
-
DNA hypomethylation in cancer cells.Epigenomics. 2009 Dec;1(2):239-59. doi: 10.2217/epi.09.33. Epigenomics. 2009. PMID: 20495664 Free PMC article. Review.
Cited by
-
Mediation of the malignant biological characteristics of gastric cancer cells by the methylated CpG islands in RNF180 DNA promoter.Oncotarget. 2016 Jul 12;7(28):43461-43474. doi: 10.18632/oncotarget.9494. Oncotarget. 2016. PMID: 27223257 Free PMC article.
-
Specific changes in the expression of imprinted genes in prostate cancer--implications for cancer progression and epigenetic regulation.Asian J Androl. 2012 May;14(3):436-50. doi: 10.1038/aja.2011.160. Epub 2012 Feb 27. Asian J Androl. 2012. PMID: 22367183 Free PMC article. Review.
-
CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cells.PLoS Genet. 2007 Sep;3(9):1757-69. doi: 10.1371/journal.pgen.0030167. Epub 2007 Aug 16. PLoS Genet. 2007. PMID: 17907813 Free PMC article.
-
Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.Genes (Basel). 2019 Jan 9;10(1):32. doi: 10.3390/genes10010032. Genes (Basel). 2019. PMID: 30634483 Free PMC article. Review.
-
Progress toward liquid biopsies in pediatric solid tumors.Cancer Metastasis Rev. 2019 Dec;38(4):553-571. doi: 10.1007/s10555-019-09825-1. Cancer Metastasis Rev. 2019. PMID: 31836951 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources